Table 1.
Clinical Characteristics of 137 patients
| Clinical characteristics | No. of patients |
|---|---|
| Age years |
Mean 53 ± 12 (21–74) Median 55 |
| Sex | |
| Male | 123 |
| Female | 14 |
| ALT (U/ml) | Mean 37 ± 30 (8–96) |
| AST (U/ml) | Mean 30 ± 15 (14–197) |
| TBiL (μmol/l) |
Mean 15.9 ± 9.2 (6.1–48) Median 13.4 |
| Child-Pugh score | |
| A | 129 |
| B | 8 |
| HBsAg | |
| Positive | 114 |
| Negative | 23 |
| Liver cirrhosis | |
| No | 31 |
| Yes | 106 |
| ICG-R15 (%) |
Mean 7.2 ± 4.0 (1–22.4) Median 6.6 |
| AFP (ng/mL) | |
| ≤ 400 | 96 |
| > 400 | 41 |
| Tumor diameter (cm) |
Mean 5.5 ± 3.9 (1–15.7) Median 4.5 |
| No. of tumor | |
| Single | 108 |
| Multiple | 29 |
| Portal vein tumor thrombosis | |
| No | 109 |
| Yes | 28 |
| BCLC stage | |
| 0 + A | 78 |
| B + C | 59 |
ALT alanine transaminase, AST aspartate aminotransferase, TBiL total bilirubin, HBsAg hepatitis B surface antigen, ICG R15 min (%) indocyanine green 15 min retention rate, AFP alpha fetoprotein, BCLC Barcelona Clinic Liver Cancer staging system